Lear Corp (LEA) stock
Close on Nov 13, 2026Market cap $5.24BP/E 9.5Yield 0.71%
Earnings
Lear's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Lear's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 3, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Oct 3, 2026 | Oct 30, 2026before the open | $5.80B | +1.8% | $2.74 | $3.71 | Release |
| Q2 FY2026ended Jul 4, 2026 | Jul 31, 2026before the open | $6.20B | +3.3% | $3.79 | $4.28 | Release |
| Q1 FY2026ended Apr 4, 2026 | May 1, 2026before the open | $5.80B | +3.6% | $3.34 | $3.87 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 4, 2026before the open | $6.00B | +5.3% | $1.58 | $3.41 | Release |
| Q3 FY2025ended Sep 27, 2025 | Oct 31, 2025before the open | $5.70B | +1.8% | $2.02 | $2.79 | Release |
| Q2 FY2025ended Jun 28, 2025 | Jul 25, 2025before the open | $6.00B | 0.0% | $3.06 | $3.47 | Release |
| Q1 FY2025ended Mar 29, 2025 | May 6, 2025before the open | $5.60B | -6.7% | $1.49 | $3.12 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 6, 2025before the open | $5.70B | -1.7% | $1.61 | $2.94 | Release |
| Q3 FY2024ended Sep 28, 2024 | Oct 24, 2024before the open | $5.60B | -3.4% | $2.41 | $2.89 | Release |
| Q2 FY2024ended Jun 29, 2024 | Jul 25, 2024before the open | $6.00B | 0.0% | $3.02 | $3.60 | Release |
| Q1 FY2024ended Mar 30, 2024 | Apr 30, 2024before the open | $6.00B | +3.4% | $1.90 | $3.18 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 6, 2024before the open | $5.80B | +7.4% | $2.18 | $3.03 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 26, 2023before the open | $5.80B | +11.5% | $2.25 | $2.87 | Release |
| Q2 FY2023ended Jul 1, 2023 | Aug 1, 2023before the open | $6.00B | +17.6% | $2.84 | $3.33 | Release |
| Q1 FY2023ended Apr 1, 2023 | Apr 27, 2023before the open | $5.80B | +11.5% | $2.41 | $2.78 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 2, 2023before the open | $5.40B | +10.2% | $1.97 | $2.81 | Release |
| Q3 FY2022ended Oct 1, 2022 | Nov 1, 2022before the open | $5.20B | +20.9% | $1.54 | $2.33 | Release |
| Q2 FY2022ended Jul 2, 2022 | Aug 2, 2022before the open | $5.10B | – | $1.14 | $1.79 | Release |
| Q1 FY2022ended Apr 2, 2022 | May 3, 2022before the open | $5.20B | – | $0.82 | $1.80 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 8, 2022before the open | $4.90B | – | $0.36 | $1.22 | Release |
| Q3 FY2021ended Oct 2, 2021 | Nov 2, 2021before the open | $4.30B | – | -$0.44 | $0.53 | Release |
| Q2 FY2021ended Jul 3, 2021 | Aug 6, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Apr 3, 2021 | May 7, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 4, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Oct 3, 2020 | Oct 30, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Lear's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net SalesGAAP | FY2026 | $23.35B – $23.75B | – | New | Oct 30, 2026 |
| Net Sales | FY2026 | $23.54B – $24.01B | $23.21B – $24.01B | Raised | Jul 31, 2026 |
| Net Salesnon-GAAP | FY2026 | $23.21B – $24.01B | – | New | Feb 4, 2026 |
| Core Operating Earningsnon-GAAP | FY2026 | $1.08B – $1.20B | – | New | Oct 30, 2026 |
| Core Operating Earningsnon-GAAP | FY2026 | $1.08B – $1.20B | $1.03B – $1.20B | Raised | Jul 31, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $1.70B – $1.82B | – | New | Oct 30, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $1.70B – $1.82B | $1.65B – $1.82B | Raised | Jul 31, 2026 |
| Free Cash Flownon-GAAP | FY2026 | $565.00M – $665.00M | – | New | Oct 30, 2026 |
| Free Cash Flownon-GAAP | FY2026 | $590.00M – $690.00M | $550.00M – $650.00M | Raised | Jul 31, 2026 |
| Capital Spending | FY2026 | $660.00M | – | New | Oct 30, 2026 |
| Capital Spending | FY2026 | $660.00M | $660.00M | Reaffirmed | Jul 31, 2026 |
| Capital Spendingnon-GAAP | FY2026 | $660.00M | – | New | Feb 4, 2026 |
| Operating Cash FlowGAAP | FY2026 | $1.23B – $1.33B | – | New | Oct 30, 2026 |
| Operating Cash Flow | FY2026 | $1.25B – $1.35B | $1.21B – $1.31B | Raised | Jul 31, 2026 |
| Operating Cash Flownon-GAAP | FY2026 | $1.21B – $1.31B | – | Raised | Feb 4, 2026 |
| Restructuring Costs | FY2026 | $200.00M | – | New | Oct 30, 2026 |
| Restructuring Costsnon-GAAP | FY2026 | $175.00M | $175.00M | Lowered | Jul 31, 2026 |
| Restructuring Costs | FY2026 | $175.00M | – | New | May 1, 2026 |
Guidance vs results
The last range Lear gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $22.85B – $23.15B | $23.30BΣ4Q | Above range |
Guidance history
Every forecast Lear put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 30, 2026 | Capital Spending | FY2026 | $660.00M | New |
| Oct 30, 2026 | Adjusted EBITDA | FY2026 | $1.70B – $1.82B | New |
| Oct 30, 2026 | Free Cash Flow | FY2026 | $565.00M – $665.00M | New |
| Oct 30, 2026 | Core Operating Earnings | FY2026 | $1.08B – $1.20B | New |
| Oct 30, 2026 | Operating Cash Flow | FY2026 | $1.23B – $1.33B | New |
| Oct 30, 2026 | Restructuring Costs | FY2026 | $200.00M | New |
| Oct 30, 2026 | Net Sales | FY2026 | $23.35B – $23.75B | New |
| Jul 31, 2026 | Capital Spending | FY2026 | $660.00M | Reaffirmed |
| Jul 31, 2026 | Adjusted EBITDA | FY2026 | $1.70B – $1.82B | Raised |
| Jul 31, 2026 | Free Cash Flow | FY2026 | $590.00M – $690.00M | Raised |
| Jul 31, 2026 | Core Operating Earnings | FY2026 | $1.08B – $1.20B | Raised |
| Jul 31, 2026 | Operating Cash Flow | FY2026 | $1.25B – $1.35B | Raised |
| Jul 31, 2026 | Restructuring Costs | FY2026 | $175.00M | Lowered |
| Jul 31, 2026 | Net Sales | FY2026 | $23.54B – $24.01B | Raised |
| May 1, 2026 | Capital Spending | FY2026 | $660.00M | New |
| May 1, 2026 | Adjusted EBITDA | FY2026 | $1.65B – $1.82B | Reaffirmed |
| May 1, 2026 | Free Cash Flow | FY2026 | $550.00M – $650.00M | Reaffirmed |
| May 1, 2026 | Core Operating Earnings | FY2026 | $1.03B – $1.20B | Reaffirmed |
| May 1, 2026 | Restructuring Costs | FY2026 | $175.00M | New |
| May 1, 2026 | Operating Cash Flow | FY2026 | $1.21B – $1.31B | Raised |
| May 1, 2026 | Net Sales | FY2026 | $23.21B – $24.01B | New |
| Feb 4, 2026 | Capital Spending | FY2026 | $660.00M | New |
| Feb 4, 2026 | Adjusted EBITDA | FY2026 | $1.65B – $1.82B | New |
| Feb 4, 2026 | Free Cash Flow | FY2026 | $550.00M – $650.00M | New |
| Feb 4, 2026 | Core Operating Earnings | FY2026 | $1.03B – $1.20B | New |
| Feb 4, 2026 | Restructuring Costs | FY2026 | $175.00M | New |
| Feb 4, 2026 | Operating Cash Flow | FY2026 | $1.21B – $1.31B | Raised |
| Feb 4, 2026 | Net Sales | FY2026 | $23.21B – $24.01B | New |
| Oct 31, 2025 | Capital Spending | FY2025 | $560.00M | New |
| Oct 31, 2025 | Adjusted EBITDA | FY2025 | $1.61B – $1.67B | New |
| Oct 31, 2025 | Free Cash Flow | FY2025 | $475.00M – $525.00M | New |
| Oct 31, 2025 | Core Operating Earnings | FY2025 | $995.00M – $1.06B | New |
| Oct 31, 2025 | Restructuring Costs | FY2025 | $235.00M | New |
| Oct 31, 2025 | Operating Cash Flow | FY2025 | $1.04B – $1.09B | Raised |
| Oct 31, 2025 | Net Sales | FY2025 | $22.85B – $23.15B | New |
| Jul 25, 2025 | Capital Spending | FY2025 | $590.00M | Lowered |
| Jul 25, 2025 | Adjusted EBITDA | FY2025 | $1.57B – $1.71B | Narrowed |
| Jul 25, 2025 | Free Cash Flow | FY2025 | $420.00M – $520.00M | Lowered |
| Jul 25, 2025 | Core Operating Earnings | FY2025 | $955.00M – $1.10B | Narrowed |
| Jul 25, 2025 | Restructuring Costs | FY2025 | $215.00M | Lowered |
| Jul 25, 2025 | Operating Cash Flow | FY2025 | $1.01B – $1.11B | Raised |
| Jul 25, 2025 | Net Sales | FY2025 | $22.47B – $23.07B | Raised |
| Feb 6, 2025 | Capital Spending | FY2025 | $625.00M | New |
| Feb 6, 2025 | Adjusted EBITDA | FY2025 | $1.54B – $1.80B | New |
| Feb 6, 2025 | Free Cash Flow | FY2025 | $430.00M – $630.00M | New |
| Feb 6, 2025 | Core Operating Earnings | FY2025 | $915.00M – $1.18B | New |
| Feb 6, 2025 | Restructuring Costs | FY2025 | $175.00M | New |
| Feb 6, 2025 | Operating Cash Flow | FY2025 | $1.06B – $1.26B | New |
| Feb 6, 2025 | Net Sales | FY2025 | $21.88B – $22.88B | New |
| Oct 24, 2024 | Capital Spending | FY2024 | $575.00M | Lowered |
| Oct 24, 2024 | Adjusted EBITDA | FY2024 | $1.67B – $1.72B | Lowered |
| Oct 24, 2024 | Free Cash Flow | FY2024 | $535.00M – $585.00M | Narrowed |
| Oct 24, 2024 | Core Operating Earnings | FY2024 | $1.04B – $1.09B | Narrowed |
| Oct 24, 2024 | Restructuring Costs | FY2024 | $150.00M | Reaffirmed |
| Oct 24, 2024 | Operating Cash Flow | FY2024 | $1.11B – $1.16B | Raised |
| Oct 24, 2024 | Net Sales | FY2024 | $22.95B – $23.15B | New |
| Jul 25, 2024 | Capital Spending | FY2024 | $650.00M | Lowered |
| Jul 25, 2024 | Adjusted EBITDA | FY2024 | $1.67B – $1.84B | Lowered |
| Jul 25, 2024 | Free Cash Flow | FY2024 | $485.00M – $635.00M | Lowered |
| Jul 25, 2024 | Core Operating Earnings | FY2024 | $1.03B – $1.20B | Lowered |
| Jul 25, 2024 | Restructuring Costs | FY2024 | $150.00M | Raised |
| Jul 25, 2024 | Operating Cash Flow | FY2024 | $1.14B – $1.29B | Lowered |
| Jul 25, 2024 | Net Sales | FY2024 | $23.23B – $23.67B | Lowered |
| Apr 30, 2024 | Capital Spending | FY2024 | $675.00M | New |
| Apr 30, 2024 | Adjusted EBITDA | FY2024 | $1.80B – $1.95B | Reaffirmed |
| Apr 30, 2024 | Free Cash Flow | FY2024 | $600.00M – $750.00M | Reaffirmed |
| Apr 30, 2024 | Core Operating Earnings | FY2024 | $1.16B – $1.31B | Reaffirmed |
| Apr 30, 2024 | Operating Cash Flow | FY2024 | $1.28B – $1.43B | Raised |
| Apr 30, 2024 | Restructuring Costs | FY2024 | $125.00M | Lowered |
| Apr 30, 2024 | Net Sales | FY2024 | $24.00B – $24.60B | Reaffirmed |
| Feb 6, 2024 | Capital Spending | FY2024 | $675.00M | New |
| Feb 6, 2024 | Adjusted EBITDA | FY2024 | $1.80B – $1.95B | New |
| Feb 6, 2024 | Free Cash Flow | FY2024 | $600.00M – $750.00M | New |
| Feb 6, 2024 | Core Operating Earnings | FY2024 | $1.16B – $1.31B | New |
| Feb 6, 2024 | Operating Cash Flow | FY2024 | $1.28B – $1.43B | New |
| Feb 6, 2024 | Restructuring Costs | FY2024 | $125.00M | New |
| Feb 6, 2024 | Net Sales | FY2024 | $24.00B – $24.60B | New |
| Oct 26, 2023 | Capital Spending | FY2023 | $675.00M | New |
| Oct 26, 2023 | Adjusted EBITDA | FY2023 | $1.69B – $1.73B | Narrowed |
| Oct 26, 2023 | Free Cash Flow | FY2023 | $555.00M – $595.00M | Raised |
| Oct 26, 2023 | Core Operating Earnings | FY2023 | $1.09B – $1.13B | Narrowed |
| Oct 26, 2023 | Restructuring Costs | FY2023 | $125.00M | New |
| Oct 26, 2023 | Operating Cash Flow | FY2023 | $1.23B – $1.27B | Narrowed |
| Oct 26, 2023 | Net Sales | FY2023 | $23.10B – $23.30B | Raised |
| Aug 1, 2023 | Capital Spending | FY2023 | $700.00M | Reaffirmed |
| Aug 1, 2023 | Adjusted EBITDA | FY2023 | $1.61B – $1.74B | Raised |
| Aug 1, 2023 | Free Cash Flow | FY2023 | $480.00M – $580.00M | Raised |
| Aug 1, 2023 | Core Operating Earnings | FY2023 | $1.01B – $1.14B | Raised |
| Aug 1, 2023 | Restructuring Costs | FY2023 | $100.00M | Lowered |
| Aug 1, 2023 | Operating Cash Flow | FY2023 | $1.18B – $1.28B | Raised |
| Aug 1, 2023 | Net Sales | FY2023 | $22.35B – $23.05B | Raised |
| Apr 27, 2023 | Capital Spending | FY2023 | $700.00M | Reaffirmed |
| Apr 27, 2023 | Adjusted EBITDA | FY2023 | $1.48B – $1.68B | Reaffirmed |
| Apr 27, 2023 | Free Cash Flow | FY2023 | $375.00M – $525.00M | Reaffirmed |
| Apr 27, 2023 | Core Operating Earnings | FY2023 | $875.00M – $1.08B | Reaffirmed |
| Apr 27, 2023 | Restructuring Costs | FY2023 | $100.00M | Lowered |
| Apr 27, 2023 | Operating Cash Flow | FY2023 | $1.08B – $1.23B | Raised |
| Apr 27, 2023 | Net Sales | FY2023 | $21.20B – $22.20B | Reaffirmed |
| Feb 2, 2023 | Capital Spending | FY2023 | $700.00M | New |
| Feb 2, 2023 | Adjusted EBITDA | FY2023 | $1.48B – $1.68B | New |
| Feb 2, 2023 | Free Cash Flow | FY2023 | $375.00M – $525.00M | New |
| Feb 2, 2023 | Core Operating Earnings | FY2023 | $875.00M – $1.08B | New |
| Feb 2, 2023 | Operating Cash Flow | FY2023 | $1.08B – $1.23B | Raised |
| Feb 2, 2023 | Restructuring Costs | FY2023 | $100.00M | New |
| Feb 2, 2023 | Net Sales | FY2023 | $21.20B – $22.20B | New |
| Nov 1, 2022 | Capital Spending | FY2022 | $675.00M – $700.00M | Reaffirmed |
| Nov 1, 2022 | Adjusted EBITDA | FY2022 | $1.41B – $1.51B | Reaffirmed |
| Nov 1, 2022 | Free Cash Flow | FY2022 | $275.00M – $375.00M | Reaffirmed |
| Nov 1, 2022 | Core Operating Earnings | FY2022 | $815.00M – $915.00M | Reaffirmed |
| Nov 1, 2022 | Restructuring Costs | FY2022 | $150.00M | Reaffirmed |
| Nov 1, 2022 | Operating Cash Flow | FY2022 | $950.00M – $1.08B | Reaffirmed |
| Nov 1, 2022 | Net Sales | FY2022 | $20.55B – $21.05B | Reaffirmed |
| Aug 2, 2022 | Capital Spending | FY2022 | $675.00M – $700.00M | New |
| Aug 2, 2022 | Adjusted EBITDA | FY2022 | $1.41B – $1.51B | Narrowed |
| Aug 2, 2022 | Free Cash Flow | FY2022 | $275.00M – $375.00M | Narrowed |
| Aug 2, 2022 | Core Operating Earnings | FY2022 | $815.00M – $915.00M | Narrowed |
| Aug 2, 2022 | Restructuring Costs | FY2022 | $150.00M | Lowered |
| Aug 2, 2022 | Operating Cash Flow | FY2022 | $950.00M – $1.08B | Raised |
| Aug 2, 2022 | Net Sales | FY2022 | $20.55B – $21.05B | Narrowed |
| May 3, 2022 | Capital Spending | FY2022 | $650.00M – $700.00M | Reaffirmed |
| May 3, 2022 | Adjusted EBITDA | FY2022 | $1.37B – $1.57B | Lowered |
| May 3, 2022 | Free Cash Flow | FY2022 | $225.00M – $425.00M | Lowered |
| May 3, 2022 | Core Operating Earnings | FY2022 | $765.00M – $965.00M | Lowered |
| May 3, 2022 | Restructuring Costs | FY2022 | $150.00M | Raised |
| May 3, 2022 | Operating Cash Flow | FY2022 | $875.00M – $1.13B | New |
| May 3, 2022 | Net Sales | FY2022 | $20.40B – $21.20B | Lowered |
| Feb 8, 2022 | Capital Spending | FY2022 | $650.00M – $700.00M | New |
| Feb 8, 2022 | Adjusted EBITDA | FY2022 | $1.50B – $1.80B | New |
| Feb 8, 2022 | Free Cash Flow | FY2022 | $300.00M – $600.00M | New |
| Feb 8, 2022 | Core Operating Earnings | FY2022 | $900.00M – $1.20B | New |
| Feb 8, 2022 | Restructuring Costs | FY2022 | $125.00M | New |
| Feb 8, 2022 | Net Sales | FY2022 | $20.80B – $22.30B | New |
| Nov 2, 2021 | Capital Spending | FY2021 | $600.00M | New |
| Nov 2, 2021 | Adjusted EBITDA | FY2021 | $1.31B – $1.41B | New |
| Nov 2, 2021 | Free Cash Flow | FY2021 | $175.00M | New |
| Nov 2, 2021 | Core Operating Earnings | FY2021 | $750.00M – $850.00M | New |
| Nov 2, 2021 | Restructuring Costs | FY2021 | $100.00M | New |
| Nov 2, 2021 | Net Sales | FY2021 | $18.80B – $19.20B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Lear filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- News
- Results
See a number that looks wrong?